CD82 controls CpG-dependent TLR9 signaling
- PMID: 31408613
- PMCID: PMC6988855
- DOI: 10.1096/fj.201901547R
CD82 controls CpG-dependent TLR9 signaling
Abstract
The tetraspanin CD82 is a potent suppressor of tumor metastasis and regulates several processes including signal transduction, cell adhesion, motility, and aggregation. However, the mechanisms by which CD82 participates in innate immunity are unknown. We report that CD82 is a key regulator of TLR9 trafficking and signaling. TLR9 recognizes unmethylated cytosine-phosphate-guanine (CpG) motifs present in viral, bacterial, and fungal DNA. We demonstrate that TLR9 and CD82 associate in macrophages, which occurs in the endoplasmic reticulum (ER) and post-ER. Moreover, CD82 is essential for TLR9-dependent myddosome formation in response to CpG stimulation. Finally, CD82 modulates TLR9-dependent NF-κB nuclear translocation, which is critical for inflammatory cytokine production. To our knowledge, this is the first time a tetraspanin has been implicated as a key regulator of TLR signaling. Collectively, our study demonstrates that CD82 is a specific regulator of TLR9 signaling, which may be critical in cancer immunotherapy approaches and coordinating the innate immune response to pathogens.-Khan, N. S., Lukason, D. P., Feliu, M., Ward, R. A., Lord, A. K., Reedy, J. L., Ramirez-Ortiz, Z. G., Tam, J. M., Kasperkovitz, P. V., Negoro, P. E., Vyas, T. D., Xu, S., Brinkmann, M. M., Acharaya, M., Artavanis-Tsakonas, K., Frickel, E.-M., Becker, C. E., Dagher, Z., Kim, Y.-M., Latz, E., Ploegh, H. L., Mansour, M. K., Miranti, C. K., Levitz, S. M., Vyas, J. M. CD82 controls CpG-dependent TLR9 signaling.
Keywords: TLRs; macrophages; myddosome; tetraspanins.
Conflict of interest statement
The authors thank Nicole Wolf for the artwork displayed in the graphical abstract (Fig. 7), Shizuo Akira (Osaka University, Osaka, Japan) for the TLR9 knockout (TLR9KO) mice, and Douglas Golenbock (University of Massachusetts Medical Center, Worcester, MA, USA) for the TLR9KO macrophage cell line. The authors also thank Kensuyke Miyake and Ryutaro Fukui (University of Tokyo, Tokyo, Japan) for the TLR9 monoclonal and polyclonal antibodies (41), and Gregory Barton and Bo Liu (University of California–Berkeley, Berkeley, CA, USA) for the TLR7-FLAG construct. This work was supported by U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grants R01 AI092084 and R01 AI097519 (to J.M.V.) and R01 AI025780 and R01 AI139615 (to S.M.L.). This work was also supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001076), the UK Medical Research Council (FC001076), and the Wellcome Trust (FC001076). The authors declare no conflicts of interest.
Figures
References
-
- Hemler M. E. (2005) Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 6, 801–811 - PubMed
-
- Van Spriel A. B., Figdor C. G. (2010) The role of tetraspanins in the pathogenesis of infectious diseases. Microbes Infect. 12, 106–112 - PubMed
-
- Hemler M. E. (2014) Tetraspanin proteins promote multiple cancer stages. Nat. Rev. Cancer 14, 49–60 - PubMed
-
- Yáñez-Mó M., Barreiro O., Gordon-Alonso M., Sala-Valdés M., Sánchez-Madrid F. (2009) Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol. 19, 434–446 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
